Friday, April 12, 2024 7:53:55 PM
One obvious reason NWBO might have chosen to submit first with MHRA is that a cash strapped company needed to wait out guidance changes at FDA where big pharma has considerable influence. They might have also considered the promising innovative medicine (PIM) and National Priority designations as a sign that MHRA was ready to act favorably without the heavy influence of big pharma getting in the way. No designations like that in the states anywhere to be seen.
Linda understands leverage and big pharma has it with FDA, media and politicians. Consider that no politicians are openly talking about DCVax in the US and yet in the UK there are discussions about the need for brain tumor research, trials and other which leads to mentions of DCVax in those circles. The media has been almost dead silent about advances with DCVax development while Cambridge outlets and others have been talking about NWBO and Advent. MHRA is likely more influenced by high ranking clinicians like Dr Keyoumars Ashkan and advocacy groups than by big pharma. All in all there is a more favorable climate in the UK than in the USA. Linda will always start where she has a better chance to gain traction and a few years back she and others were able to be present with government officials at a health care meeting that I think Lykiri shared pictures of. I have never seen anything like that happen in the USA. Best wishes.
Recent NWBO News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM